As part of the validation, we revealed that the albumin and doxorubicin conjugate (HSA‐TC‐proDOX) exhibited good tumor targeting in vivo and enhanced cancer cellular uptake in vitro (Figure 2d,e). Here, ALB is linked to cancer.